Literature DB >> 31811531

Adapted physical activity and therapeutic exercise in late-onset Pompe disease (LOPD): a two-step rehabilitative approach.

Giovanni Iolascon1, Michele Vitacca2, Elena Carraro3, Carmelo Chisari4, Pietro Fiore5, Sonia Messina6, Tiziana Mongini7, Antimo Moretti8, Valeria A Sansone3, Antonio Toscano6, Gabriele Siciliano9.   

Abstract

Aerobic exercise, training to sustain motor ability, and respiratory rehabilitation may improve general functioning and quality of life (QoL) in neuromuscular disorders. Patients with late-onset Pompe disease (LOPD) typically show progressive muscle weakness, respiratory dysfunction and minor cardiac involvement. Characteristics and modalities of motor and respiratory rehabilitation in LOPD are not well defined and specific guidelines are lacking. Therefore, we evaluated the role of physical activity, therapeutic exercise, and pulmonary rehabilitation programs in order to promote an appropriate management of motor and respiratory dysfunctions and improve QoL in patients with LOPD. We propose two operational protocols: one for an adapted physical activity (APA) plan and the other for an individual rehabilitation plan, particularly focused on therapeutic exercise (TE) and respiratory rehabilitation.

Entities:  

Keywords:  Adapted physical activity; Glycogen storage disease type II; ICF; Pompe disease; Rehabilitation; Therapeutic exercise

Mesh:

Year:  2019        PMID: 31811531     DOI: 10.1007/s10072-019-04178-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  52 in total

Review 1.  Enzyme therapy for Pompe disease: from science to industrial enterprise.

Authors:  Arnold J J Reuser; Hannerieke Van Den Hout; Agnes G A Bijvoet; Marian A Kroos; Martin P Verbeet; Ans T Van Der Ploeg
Journal:  Eur J Pediatr       Date:  2002-08-13       Impact factor: 3.183

2.  Role of the cardio-pulmonary exercise test and six-minute walking test in the evaluation of exercise performance in patients with late-onset Pompe disease.

Authors:  G Crescimanno; R Modica; R Lo Mauro; O Musumeci; A Toscano; O Marrone
Journal:  Neuromuscul Disord       Date:  2015-03-23       Impact factor: 4.296

3.  Rasch analysis of the Fatigue Severity Scale in Italian subjects with multiple sclerosis.

Authors:  Marcella Ottonello; Leonardo Pellicciari; Andrea Giordano; Calogero Foti
Journal:  J Rehabil Med       Date:  2016-07-18       Impact factor: 2.912

Review 4.  Pompe's disease.

Authors:  Ans T van der Ploeg; Arnold J J Reuser
Journal:  Lancet       Date:  2008-10-11       Impact factor: 79.321

5.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

Authors:  J D Fisk; P G Ritvo; L Ross; D A Haase; T J Marrie; W F Schlech
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

6.  Aerobic capacities and exercise tolerance in neuromuscular diseases: a descriptive study.

Authors:  A Rapin; A Etossé; L Tambosco; J Nicomette; L Percebois-Macadré; P Mouret; F C Boyer
Journal:  Ann Phys Rehabil Med       Date:  2013-04-30

7.  Metabolic myopathies: functional evaluation by analysis of oxygen uptake kinetics.

Authors:  Bruno Grassi; Simone Porcelli; Mauro Marzorati; Francesca Lanfranconi; Paola Vago; Claudio Marconi; Lucia Morandi
Journal:  Med Sci Sports Exerc       Date:  2009-12       Impact factor: 5.411

Review 8.  Stretch for the treatment and prevention of contractures.

Authors:  Lisa A Harvey; Owen M Katalinic; Robert D Herbert; Anne M Moseley; Natasha A Lannin; Karl Schurr
Journal:  Cochrane Database Syst Rev       Date:  2017-01-09

Review 9.  Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease.

Authors:  Matthias Boentert; Hélène Prigent; Katalin Várdi; Harrison N Jones; Uwe Mellies; Anita K Simonds; Stephan Wenninger; Emilia Barrot Cortés; Marco Confalonieri
Journal:  Int J Mol Sci       Date:  2016-10-17       Impact factor: 5.923

Review 10.  The role of rehabilitation in the management of late-onset Pompe disease: a narrative review of the level of evidence.

Authors:  Giovanni Iolascon; Michele Vitacca; Elena Carraro; Carmelo Chisari; Pietro Fiore; Sonia Messina; Tiziana Enrica Giovanna Mongini; Valeria A Sansone; Antonio Toscano; Gabriele Siciliano
Journal:  Acta Myol       Date:  2018-12-01
View more
  2 in total

1.  What is the role of magnesium for skeletal muscle cramps? A Cochrane Review summary with commentary.

Authors:  Antimo Moretti
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-03-01       Impact factor: 2.041

2.  Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019).

Authors:  Maria Elena Lombardo; Elena Carraro; Cristina Sancricca; Michela Armando; Michela Catteruccia; Elena Mazzone; Giulia Ricci; Ferdinando Salamino; Filippo Maria Santorelli; Massimiliano Filosto
Journal:  Acta Myol       Date:  2021-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.